Home/Filings/4/0000950170-23-045450
4//SEC Filing

Keutzer Timothy 4

Accession 0000950170-23-045450

CIK 0001701108other

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 4:23 PM ET

Size

4.9 KB

Accession

0000950170-23-045450

Insider Transaction Report

Form 4
Period: 2023-08-28
Keutzer Timothy
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2023-08-28$1.26/sh1,854$2,336325,290 total
Footnotes (1)
  • [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.

Documents

1 file

Issuer

Spero Therapeutics, Inc.

CIK 0001701108

Entity typeother

Related Parties

1
  • filerCIK 0001798155

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:23 PM ET
Size
4.9 KB